Majedie Asset Management’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
$7.22M Buy
195,492
+19,984
+11% +$738K 0.59% 58
2021
Q4
$5.35M Hold
175,508
0.41% 66
2021
Q3
$5.89M Sell
175,508
-8,954
-5% -$300K 0.45% 66
2021
Q2
$7.36M Buy
184,462
+62,763
+52% +$2.5M 0.48% 68
2021
Q1
$5.47M Buy
121,699
+7,863
+7% +$354K 0.4% 71
2020
Q4
$6.44M Buy
113,836
+22,219
+24% +$1.26M 0.49% 59
2020
Q3
$4.35M Buy
91,617
+5,494
+6% +$261K 0.32% 59
2020
Q2
$5.08M Buy
86,123
+3,746
+5% +$221K 0.39% 49
2020
Q1
$3.9M Sell
82,377
-993
-1% -$47.1K 0.36% 46
2019
Q4
$5.04M Buy
83,370
+12,514
+18% +$757K 0.37% 55
2019
Q3
$4.25M Sell
70,856
-8,795
-11% -$527K 0.36% 58
2019
Q2
$5.13M Buy
79,651
+2,866
+4% +$185K 0.39% 52
2019
Q1
$6.24M Sell
76,785
-22,260
-22% -$1.81M 0.44% 50
2018
Q4
$5.48M Sell
99,045
-23,407
-19% -$1.29M 0.41% 47
2018
Q3
$6.32M Buy
122,452
+18,253
+18% +$941K 0.48% 44
2018
Q2
$4.34M Buy
104,199
+12,500
+14% +$521K 0.34% 52
2018
Q1
$4.04M Buy
91,699
+11,003
+14% +$485K 0.37% 55
2017
Q4
$4.06M Buy
80,696
+6,500
+9% +$327K 0.34% 55
2017
Q3
$3.76M Hold
74,196
0.31% 55
2017
Q2
$3.77M Hold
74,196
0.36% 51
2017
Q1
$2.98M Buy
74,196
+7,128
+11% +$287K 0.32% 56
2016
Q4
$3.21M Buy
67,068
+40,618
+154% +$1.94M 0.43% 51
2016
Q3
$969K Buy
26,450
+3,700
+16% +$136K 0.16% 59
2016
Q2
$530K Buy
22,750
+2,999
+15% +$69.9K 0.09% 62
2016
Q1
$800K Buy
19,751
+5,578
+39% +$226K 0.12% 59
2015
Q4
$878K Buy
14,173
+407
+3% +$25.2K 0.12% 55
2015
Q3
$556K Buy
13,766
+4,669
+51% +$189K 0.09% 57
2015
Q2
$524K Buy
9,097
+6,096
+203% +$351K 0.09% 55
2015
Q1
$191K Buy
3,001
+484
+19% +$30.8K 0.04% 58
2014
Q4
$155K Buy
+2,517
New +$155K 0.03% 61